Abstract
Objective: This present study aims to identify the incidence of post-COVID-19 pericarditis in patients seen at a cardiology clinic, as well as to discuss risk factors and possible therapies. Methods: Data collection was performed through the research protocol on medical records of patients seen at the clinic, seeking to identify patients with COVID-19 and those who developed pericarditis. All data were tabulated using Microsoft Excel software and statistical analysis performed using the Biostat 5.0 program. Results: In our study, we found 4 patients who evolved with acute pericarditis after COVID-19, with an incidence of 11.76%. Most patients had cardiocerebrovascular comorbidities, which are known to be associated with a worse prognosis and morbidity and mortality in SARS-CoV-2 infection. All patients had a favorable clinical outcome after treatment with the usual therapeutic dose with colchicine. Conclusion: It is concluded that despite the late complication of COVID-19, acute pericarditis in the study series, maintained its self-limited pattern, as well as its relevant incidence rate ensures cardiac manifestations as one of the main and most impotent of COVID-19 extrapulmonary manifestations.